Northern Trust’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-54
| Closed | -$37.9K | – | 4562 |
|
|
2023
Q3 | $37.9K | Hold |
54
| – | – | ﹤0.01% | 4230 |
|
|
2023
Q2 | $246K | Buy |
54
+3
| +6% | +$10.4K | ﹤0.01% | 3745 |
|
|
2023
Q1 | $136K | Buy |
51
+3
| +6% | +$8.78K | ﹤0.01% | 3995 |
|
|
2022
Q4 | $125K | Hold |
48
| – | – | ﹤0.01% | 4021 |
|
|
2022
Q3 | $189K | Buy |
48
+1
| +2% | +$3.93K | ﹤0.01% | 3896 |
|
|
2022
Q2 | $121K | Sell |
47
-179
| -79% | -$466K | ﹤0.01% | 4096 |
|
|
2022
Q1 | $728K | Sell |
226
-10
| -4% | -$43K | ﹤0.01% | 3582 |
|
|
2021
Q4 | $1.48M | Sell |
236
-2
| -0.8% | -$15.4K | ﹤0.01% | 3374 |
|
|
2021
Q3 | $2.2M | Buy |
238
+40
| +20% | +$344K | ﹤0.01% | 3236 |
|
|
2021
Q2 | $2.01M | Buy |
198
+166
| +519% | +$2.73M | ﹤0.01% | 3354 |
|
|
2021
Q1 | $611K | Buy |
32
+9
| +39% | +$105K | ﹤0.01% | 3755 |
|
|
2020
Q4 | $142K | Buy |
23
+2
| +10% | +$7.85K | ﹤0.01% | 4043 |
|
|
2020
Q3 | $75K | Sell |
21
-4
| -16% | -$14.4K | ﹤0.01% | 4029 |
|
|
2020
Q2 | $99K | Buy |
25
+17
| +213% | +$56.4K | ﹤0.01% | 3925 |
|
|
2020
Q1 | $14K | Buy |
8
+3
| +60% | +$11.2K | ﹤0.01% | 4127 |
|
|
2019
Q4 | $26K | Sell |
5
-2
| -29% | -$7.67K | ﹤0.01% | 4135 |
|
|
2019
Q3 | $25K | Buy |
7
+4
| +133% | +$24.1K | ﹤0.01% | 4139 |
|
|
2019
Q2 | $25K | Buy |
+3
| New | +$31.6K | ﹤0.01% | 4149 |
|
|
2019
Q1 | – | Hold |
0
| – | -$3K | – | 4267 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4251 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4280 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4272 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4220 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4129 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4150 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 4202 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 4126 |
|
|
2016
Q4 | – | Hold |
0
| – | -$23K | – | 4211 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4093 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4062 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 4017 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3965 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 3870 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 3891 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 3914 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 4063 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 4029 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 3934 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 3876 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 3812 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 3825 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 3799 |
|
Other funds holding SEEL
WE
AI
GJL
MWM
Northern Trust's SEEL Position: Q4 2023 in Review
Northern Trust sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2023, closing a stake of 54 shares — an estimated $37.9K sold.
Northern Trust first reported a position in SEEL in Q2 2019 and held it in 18 quarters. The position peaked at $2.2M in Q3 2021. 32 funds tracked by Wall St. Rank hold SEEL as of Q4 2023.
- Northern Trust reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Northern Trust sold 54 Seelos Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $37.9K.
- Northern Trust first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2019 and held it in 18 quarters.
- Northern Trust's Seelos Therapeutics, Inc. Common Stock position peaked at $2.2M in Q3 2021.
- 32 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2023.
Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.